Literature DB >> 17642534

High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.

Mami Hata1, Masako Tsuzuki, Yasuhiro Goto, Norimichi Kumagai, Miki Harada, Michiko Hashimoto, Seidai Tanaka, Kenji Sakae, Takashi Kimura, Hiroko Minagawa, Yutaka Miyazaki.   

Abstract

Using the newly designed mismatch amplification mutation assay (MAMA) PCR, we demonstrated the high frequency of amantadine-resistant influenza A (H3N2) viruses isolated during the 2005-2006 season by detecting the mutation at amino acid position 31 of the M2 protein (S31N). Further, phylogenetic analyses of the HA1 sequences of the S31N viruses revealed that they comprised a clonal lineage that would result in the common characteristic amino acid changes at positions 193 (Ser to Phe) and 225 (Asp to Asn) of the HA protein. We also demonstrated that the S31N/S193F/D225N viruses had already emerged in Aichi Prefecture by the end of the previous 2004-2005 season.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17642534

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  11 in total

1.  Rapid genotypic assay for detection of oseltamivir-resistant influenza A (H1N1) viruses.

Authors:  Mami Hata; Seidai Tanaka; Yoshihiro Yasui; Noriko Fujiwara; Shinichi Kobayashi; Hiroko Minagawa
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

2.  Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.

Authors:  Donald F Smee; E Bart Tarbet; Yousuke Furuta; John D Morrey; Dale L Barnard
Journal:  Future Virol       Date:  2013-11       Impact factor: 1.831

3.  Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.

Authors:  E Bart Tarbet; Masako Maekawa; Yousuke Furuta; Y S Babu; John D Morrey; Donald F Smee
Journal:  Antiviral Res       Date:  2012-03-10       Impact factor: 5.970

4.  Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; E Bart Tarbet; Y S Babu; Klaus Klumpp; John D Morrey
Journal:  Antiviral Res       Date:  2010-07-13       Impact factor: 5.970

5.  Detection of the pandemic H1N1/2009 influenza A virus by a highly sensitive quantitative real-time reverse-transcription polymerase chain reaction assay.

Authors:  Zhu Yang; Guoliang Mao; Yujun Liu; Yuan-Chuan Chen; Chengjing Liu; Jun Luo; Xihan Li; Ke Zen; Yanjun Pang; Jianguo Wu; Fenyong Liu
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

6.  Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; E Bart Tarbet; John D Morrey; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

7.  Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; John D Morrey
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

8.  Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms.

Authors:  Hassan Zaraket; Hiroki Kondo; Akinobu Hibino; Ren Yagami; Takashi Odagiri; Nobuhiro Takemae; Ryota Tsunekuni; Takehiko Saito; Yi Yi Myint; Yadanar Kyaw; Khin Yi Oo; Htay Htay Tin; Nay Lin; Nguyen Phuong Anh; Nguyen Le Khanh Hang; Le Quynh Mai; Mohd R Hassan; Yugo Shobugawa; Julian Tang; Ghassan Dbaibo; Reiko Saito
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

9.  Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.

Authors:  Natalia A Ilyushina; Vladimir Y Lugovtsev; Anastasia P Samsonova; Faruk G Sheikh; Nicolai V Bovin; Raymond P Donnelly
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 10.  Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.

Authors:  Malak M Alame; Elie Massaad; Hassan Zaraket
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.